PuriCore Plc

PuriCore's solutions have applications in a range of markets, such as medical device disinfection, food safety, dental equipment, hospitality, water safety, wound management and other applications intended to limit the spread of infectious disease, including global disease threats, such as influenza, tuberculosis, norovirus, hepatitis A, legionnella and E.coli.
 
PuriCore markets a portfolio of branded systems, which produce hypochlorous acid solutions on-site at a customer's location from water, electricity and common salt. These solutions include Sterilox endoscopy (disinfects and sterilizes endoscopes and other minimally invasive medical equipment), Sterilox food safety (keeps produce, seafood, ice and floral products fresher, longer) and Sterilox dental (controls contamination in dental unit water lines, thereby reducing infection risk). Sterilox systems electrochemically generate antimicrobial hypochlorous acid (HOCl) solutions from salt and water at a range of concentrations to meet the customer needs of each application. HOCI is a well known and well characterized oxidant and is a critical chemical produced by the human body's natural immune system at a pH similar to the Sterilox Solutions to fight infection.
 
PuriCore is listed on the London Stock Exchange (ticker: PURI).]]>